Naproxennatrium Banner (Naproxen Sodium)

Naproxen sodium, the active ingredient in Naproxennatrium Banner, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral formulation for oral use. It is used to relieve pain, reduce inflammation and lower fever in adults. GNH USA supplies Naproxennatrium Banner as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Naproxennatrium Banner, an NSAID, is employed across several inflammatory and pain‑related conditions. - Osteoarthritis: reduces joint pain and improves mobility. - Rheumatoid arthritis: diminishes inflammation and joint swelling. - Acute pain: provides rapid relief of moderate to severe pain. - Fever: lowers elevated body temperature associated with infection or inflammation.

Naproxennatrium Banner may cause a range of adverse reactions.

Common Side Effects: - Dyspepsia or stomach upset - Nausea - Headache - Dizziness - Mild skin rash - Diarrhoea

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Severe renal impairment - Cardiovascular events such as myocardial infarction - Anaphylactic or severe allergic reactions - Hepatic enzyme elevation - Stevens‑Johnson syndrome or toxic epidermal necrolysis

Before prescribing Naproxennatrium Banner, clinicians should consider several safety aspects. - Assess gastrointestinal risk: evaluate history of ulcers or bleeding. - Evaluate renal function: monitor creatinine in patients with kidney disease. - Monitor cardiovascular status: use caution in patients with heart disease. - Use the lowest effective dose for the shortest duration needed. - Avoid in individuals with known hypersensitivity to naproxen or other NSAIDs. - Store at ambient temperature: keep in the original pack, protect from moisture.

Naproxennatrium Banner can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: additive gastrointestinal toxicity. - Selective serotonin reuptake inhibitors (SSRIs): heightened bleeding potential.

Moderate Interactions (Monitor Closely):\n- Diuretics: possible reduction in renal clearance. - Methotrexate: increased serum levels and toxicity.